Board Change • 6h
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 2 independent directors. 7 non-independent directors. Independent Non-Executive Director Tariq Abd al-Bari was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Aankondiging • Apr 16
Samad Misr EGYFERT.S.A.E announces Annual dividend, payable on April 30, 2026 Samad Misr EGYFERT.S.A.E announced Annual dividend of EGP 3.8350 per share payable on April 30, 2026, ex-date on April 28, 2026 and record date on April 29, 2026. Aankondiging • Feb 27
Samad Misr EGYFERT.S.A.E, Annual General Meeting, Mar 30, 2026 Samad Misr EGYFERT.S.A.E, Annual General Meeting, Mar 30, 2026, at 15:00 Egypt Standard Time. Location: giza Egypt Board Change • May 14
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Managing Director & Executive Director Sham Ahmad Al-Badawi was the last director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Aankondiging • Mar 05
Samad Misr EGYFERT.S.A.E, Annual General Meeting, Apr 28, 2025 Samad Misr EGYFERT.S.A.E, Annual General Meeting, Apr 28, 2025, at 15:00 Egypt Standard Time. Location: giza Egypt Aankondiging • Jan 20
An undisclosed buyer submitted a mandatory purchase offer to acquire an additional 57.50% stake in Samad Misr EGYFERT.S.A.E (CASE:SMFR). An undisclosed buyer submitted a mandatory purchase offer to acquire an additional 57.50% stake in Samad Misr EGYFERT.S.A.E (CASE:SMFR) on January 20, 2025. The offer includes the purchase of up to 5.52 million shares, representing 57.5% of EGYFERT's shares targeted in the transaction, for EGP 0.95 per share. Aankondiging • Jan 13
Nas Holding Offers to Raise Stake in Samad Misr EGYFERT UAE-based Nas Holding Investments has submitted an offer to raise its total capital shares of the Egyptian company Samad Misr EGYFERT.S.A.E (CASE:SMFR) from 57.5% to 90%, according to a statement posted on the Egyptian Exchange website. Nas is established under Abu Dhabi Global Market regulations. It said it does not intend to delist Egivert shares from the Egyptian Exchange. The acquisition offer is priced at EGP 95 per share. The total value of the deal is estimated at EGP 524.4 million. Trading on Egivert shares was suspended following a request from the Financial Regulatory Authority (FRA), pending a statement from the authority. The FRA stated it is monitoring the potential acquisition offer to ensure the protection of investors' rights. The FRA said the potential buyer must formally submit the acquisition offer within 60 days of announcing its intention. This period may be extended for another 60 days if the FRA deems there are valid reasons provided by the buyer. Reported Earnings • Nov 15
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: ج.م71.0m (down 2.4% from 3Q 2023). Net income: ج.م10.4m (down 31% from 3Q 2023). Profit margin: 15% (down from 21% in 3Q 2023). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 107% per year but the company’s share price has only increased by 97% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Sep 25
Upcoming dividend of ج.م6.31 per share Eligible shareholders must have bought the stock before 02 October 2024. Payment date: 07 October 2024. Payout ratio is on the higher end at 88%, and the cash payout ratio is above 100%. Trailing yield: 20%. Within top quartile of Egyptian dividend payers (6.6%). Higher than average of industry peers (6.1%). Valuation Update With 7 Day Price Move • Sep 01
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ج.م59.84, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 8x in the Chemicals industry in Egypt. Total returns to shareholders of 465% over the past three years. Reported Earnings • Aug 14
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: ج.م44.6m (down 14% from 2Q 2023). Net income: ج.م62.4m (up ج.م63.0m from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 107% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 19
First quarter 2024 earnings released First quarter 2024 results: Revenue: ج.م40.5m (down 25% from 1Q 2023). Net income: ج.م6.20m (down 79% from 1Q 2023). Profit margin: 15% (down from 55% in 1Q 2023). The decrease in margin was primarily driven by higher expenses. Valuation Update With 7 Day Price Move • May 17
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ج.م43.90, the stock trades at a trailing P/E ratio of 6.4x. Average trailing P/E is 8x in the Chemicals industry in Egypt. Total returns to shareholders of 407% over the past three years. Valuation Update With 7 Day Price Move • May 01
Investor sentiment deteriorates as stock falls 24% After last week's 24% share price decline to ج.م36.84, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 8x in the Chemicals industry in Egypt. Total returns to shareholders of 357% over the past three years. New Risk • Mar 07
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ج.م487.4m (US$9.84m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (57% accrual ratio). Market cap is less than US$10m (ج.م487.4m market cap, or US$9.84m). Minor Risk Paying a dividend despite having no free cash flows. Reported Earnings • Feb 08
Full year 2023 earnings released Full year 2023 results: Revenue: ج.م285.2m (up 7.7% from FY 2022). Net income: ج.م65.5m (up ج.م58.4m from FY 2022). Profit margin: 23% (up from 2.7% in FY 2022). The increase in margin was primarily driven by lower expenses. Reported Earnings • Nov 18
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: ج.م72.7m (down 4.3% from 3Q 2022). Net income: ج.م15.2m (up 30% from 3Q 2022). Profit margin: 21% (up from 15% in 3Q 2022). Valuation Update With 7 Day Price Move • Oct 11
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ج.م54.33, the stock trades at a trailing P/E ratio of 14.8x. Average trailing P/E is 11x in the Chemicals industry in Egypt. Total returns to shareholders of 573% over the past three years. Valuation Update With 7 Day Price Move • Sep 13
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ج.م24.61, the stock trades at a trailing P/E ratio of 6.7x. Average trailing P/E is 9x in the Chemicals industry in Egypt. Total returns to shareholders of 383% over the past three years. New Risk • Aug 25
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 39% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (39% accrual ratio). Market cap is less than US$10m (ج.م192.0m market cap, or US$6.21m). Minor Risks Dividend is not well covered by cash flows (380% cash payout ratio). Share price has been volatile over the past 3 months (6.8% average weekly change). New Risk • Jul 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Egyptian stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (ج.م190.8m market cap, or US$6.17m). Minor Risks Short dividend paying track record (less than a year of continuous dividend payments). Share price has been volatile over the past 3 months (6.8% average weekly change). Upcoming Dividend • Jul 04
Upcoming dividend of ج.م2.60 per share at 11% yield Eligible shareholders must have bought the stock before 11 July 2023. Payment date: 13 July 2023. Payout ratio is a comfortable 38% and this is well supported by cash flows. Trailing yield: 11%. Within top quartile of Egyptian dividend payers (7.5%). Higher than average of industry peers (6.1%). Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ج.م22.36, the stock trades at a trailing P/E ratio of 5.8x. Average trailing P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 267% over the past three years. Upcoming Dividend • Apr 04
Upcoming dividend of ج.م0.28 per share at 1.6% yield Eligible shareholders must have bought the stock before 11 April 2023. Payment date: 13 April 2023. Trailing yield: 1.6%. Lower than top quartile of Egyptian dividend payers (7.4%). Lower than average of industry peers (5.8%). Valuation Update With 7 Day Price Move • Dec 07
Investor sentiment improved over the past week After last week's 19% share price gain to ج.م16.42, the stock trades at a trailing P/E ratio of 64.6x. Average trailing P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 307% over the past three years. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Oct 19
Investor sentiment improved over the past week After last week's 17% share price gain to ج.م12.88, the stock trades at a trailing P/E ratio of 50.7x. Average trailing P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 231% over the past three years. Valuation Update With 7 Day Price Move • Jun 20
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ج.م9.05, the stock trades at a trailing P/E ratio of 66.7x. Average trailing P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 122% over the past three years. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Mar 29
Investor sentiment improved over the past week After last week's 20% share price gain to ج.م9.85, the stock trades at a trailing P/E ratio of 75.3x. Average trailing P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 124% over the past three years. Valuation Update With 7 Day Price Move • Feb 17
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ج.م7.59, the stock trades at a trailing P/E ratio of 35.5x. Average trailing P/E is 8x in the Chemicals industry in Egypt. Total returns to shareholders of 54% over the past three years. Reported Earnings • Mar 08
Full year 2020 earnings released The company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2020 results: Revenue: ج.م25.2m (down 19% from FY 2019). Net loss: ج.م461.2k (loss narrowed 77% from FY 2019). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth. Is New 90 Day High Low • Feb 09
New 90-day high: ج.م12.31 The company is up 46% from its price of ج.م8.42 on 11 November 2020. The Egyptian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period. Is New 90 Day High Low • Jan 19
New 90-day high: ج.م10.07 The company is up 7.0% from its price of ج.م9.39 on 21 October 2020. The Egyptian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. Is New 90 Day High Low • Dec 21
New 90-day low: ج.م7.68 The company is down 8.0% from its price of ج.م8.34 on 22 September 2020. The Egyptian market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. Aankondiging • Jul 30
Midfert Egypt for Investment acquired an additional 10.4% stake in Samad Misr EGYFERT.S.A.E (CASE:SMFR) for EGP 5.3 million. Midfert Egypt for Investment acquired an additional 10.4% stake in Samad Misr EGYFERT.S.A.E (CASE:SMFR) for EGP 5.3 million on July 13, 2020. Under the terms of the transaction, Midfert Egypt for Investment acquired an additional 1 million shares in Samad Misr EGYFERT.S.A.E. As a result of the transaction, Midfert Egypt for Investment now owns 30.47% stake in Samad Misr EGYFERT.S.A.E.
Midfert Egypt for Investment completed the acquisition of 10.4% stake in Samad Misr EGYFERT.S.A.E (CASE:SMFR) on July 13, 2020.